PharmacoEconomics

Công bố khoa học tiêu biểu

* Dữ liệu chỉ mang tính chất tham khảo

Sắp xếp:  
Guidelines for Economic Analysis of Pharmaceutical Products
PharmacoEconomics - Tập 3 - Trang 354-361 - 2012
Allan S. Detsky
Summary In Canada, provincial formulary review committees consider the effectiveness, safety, and cost of products when they derive advice for each Minister of Health. This article offers a draft set of guidelines for pharmaceutical manufacturers making submissions which include economic information, moving beyond a simple presentation of the unit price of the pharmaceutical product (e.g. price pe...... hiện toàn bộ
Cost of Illness of Glaucoma
PharmacoEconomics - Tập 27 - Trang 189-198 - 2012
Richard G. Fiscella, Jeff Lee, Elizabeth J. H. Davis, John Walt
Cost-of-illness studies determine the total financial burden of a disease by considering direct and indirect costs, including medication, diagnostics and surgery. Studies of resource use and costs associated with primary open-angle glaucoma have used varying methodologies. Most have focused on consumption of healthcare resources at various stages of disease to anticipate costs. The direct costs as...... hiện toàn bộ
A Review of Generic Preference-Based Measures for Use in Cost-Effectiveness Models
PharmacoEconomics - - 2017
John Brazier, Roberta Ara, Donna Rowen, Hélène Chevrou‐Séverac
Decision-Analytic Models to Simulate Health Outcomes and Costs in Heart Failure
PharmacoEconomics - Tập 29 - Trang 753-769 - 2012
Alexander Goehler, Benjamin P. Geisler, Jennifer M. Manne, Beate Jahn, Annette Conrads-Frank, G. Scott Gazelle, Uwe Siebert
Chronic heart failure (CHF) is a critical public health issue with increasing effect on the healthcare budgets of developed countries. Various decisionanalytic modelling approaches exist to estimate the cost effectiveness of health technologies for CHF. We sought to systematically identify these models and describe their structures. We performed a systematic literature review in MEDLINE/PreMEDLINE...... hiện toàn bộ
A Meta-Analysis of Quality-of-Life Estimates for Stroke
PharmacoEconomics - Tập 21 - Trang 191-200 - 2012
Tammy O. Tengs, Ting H. Lin
Background: Researchers performing cost-effectiveness analyses often incorporate quality-of-life (QOL) estimates. Objective: To aid analysts, we performed a meta-analysis to estimate quality of life for minor, moderate, and major stroke and assessed the relative importance of study design characteristics in predicting the quality of life of patients with stroke. ...... hiện toàn bộ
Acknowledgement
PharmacoEconomics - - 2004
NULL AUTHOR_ID
Using Age-Specific Values for Pediatric HRQoL in Cost-Effectiveness Analysis: Is There a Problem to Be Solved? If So, How?
PharmacoEconomics - - 2023
Nancy Devlin, Tianxin Pan, Mark Sculpher, Mark Jit, Elly Stolk, Donna Rowen, Ben van Hout, Richard Norman
Cost Effectiveness of Becaplermin in the Treatment of Diabetic Foot Ulcers in Four European Countries
PharmacoEconomics - Tập 19 - Trang 767-778 - 2012
Ola Ghatnekar, Ulf Persson, Michael Willis, Knut Ödegaard
Objective: The primary objective of this study was to estimate the cost effectiveness of treating diabetic foot ulcers with becaplermin (Regranex®) plus good wound care (GWC) compared with GWC alone in a variety of European healthcare settings. A secondary objective was to analyse the effect of different treatment practices on the economics of caring for diabetic foot ulcers. ...... hiện toàn bộ
Indices of Therapeutic Outcome in Pharmacoeconomic Evaluation of Drug Therapy
PharmacoEconomics - Tập 1 - Trang 155-160 - 2012
Susan F. Hurley
Retrospective Economic and Outcomes Analyses Using Non-US Databases
PharmacoEconomics - - 2007
Lizheng Shi, Eric Q. Wu, Meredith Hodges, Andrew P. Yu, Howard G. Birnbaum
Tổng số: 2,573   
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 10